Altimmune Inc. Aktie - Aktienkurs - US02155H2004

{"main_chart_height":320,"indicator_chart_height":60,"zoom":false,"show_dash":["inline-timespan"],"hover_tooltip":true,"i18n":{"de":{"Intraday":"1T","7d":"1W","1m":"1M","3m":"3M","6m":"6M","1Y":"1J","3Y":"3J","5Y":"5J","10Y":"Max","performance-view":"Sichtbare Performance"}},"hover_labels":["close","perf"],"watermark":{"imgSrc":"https:\/\/www.goyax.de\/wp-content\/themes\/goyax\/assets\/images\/goyax-logo.svg","x":0.98,"y":0.98,"opacity":0.5,"height":31,"width":150},"xAxis":{"fontFamily":"Roboto","fontSize":14},"yAxis":{"fontFamily":"Roboto","fontSize":14,"showGrid":true},"view_span":"6m","enable_intraday":true,"locked_features":{"features":["downloads-csv","timespan-10Y"],"redirect":"https:\/\/www.goyax.de\/anmelden\/?redirect=%2Faktien%2FUS02155H2004%2Faltimmune-inc%2F%3Fboerse%3Dham"},"main_instrument":{"label":"Altimmune Inc.","params":{"isin":"US02155H2004","boerse":"ham","span":"5y"},"intraday_endpoint_url":"?mode=intraday"},"chart_labels":["performance-view"]}

Börse / Markt	Letzter	Kurszeit	Gehand. Stk.	Umsatz EUR
Tradegate	2,645EUR	10:32	12.381	32.747,75
Frankfurt	2,600EUR	10:12	1.000	2.600,00
Düsseldorf	2,520EUR	09:30
Hamburg	2,640EUR	08:12
München	2,688EUR	08:06
L&S	2,555EUR	12:14
Stuttgart	2,555EUR	11:31
Quotrix	2,955EUR	22.04.

Statistiken

	7 Tage	1 Monat
Performance [%]	-8,33	-6,08
Volatilität [%]	80,27	72,60
Sharpe-Ratio	2,154	1,165
Hoch	3,015	3,015
Tief	2,640	2,545
Hist. Kurs	2,880	2,811
∅-Preis	2,941	2,821
∅-Volumen
Max. Verlust [%]	-4,992	-14,22
Max. Verlustperiode (Handelstage)	1	15
Max. Verlustperiode (Kalendertage)	3	23

Kurzmeldungen

Altimmune Inc.

2,645 -11,69%

26.06.2025 Das experimentelle Adipositas-Medikament Pemvidutid von Altimmune hat zwar bei Patienten mit einer bestimmten Form der Fettleber positive Effekte gezeigt und half dabei, die Erkrankung zu überwinden. Eine deutliche Verbesserung der Leberfibrose oder -vernarbung ließ sich jedoch statistisch nicht nachweisen. "Auch wenn die Gesamtergebnisse vielversprechend wirken, dürfte das Ausbleiben signifikanter Fortschritte bei der Fibrose schwer zu vermitteln sein", so Jonathan Wolleben, Analyst bei der Citizens Bank.

Quelle: Goyax-Redaktion

Mehr

Quotes

Geld (12:00)2,520
Brief (12:00)2,665
Spread (in %)0,1450 (5,75 %)
Geld Stk.10.100
Brief Stk.9.500

Kursdaten

Eröffnungskurs2,640
Tageshoch2,640
Tagestief2,640
Kurs (08:12)2,640

Kursdaten Vortag

Vortag-Eröffnung2,950
Vortag-Hoch2,950
Vortag-Tief2,950
Vortag-Schlusskurs2,950

Stammdaten

WertpapiertypAktie
ISINUS02155H2004
WKNA2N5Z6
HerkunftUSA
NotierungseinheitStück

Ihre technische Chartanalyse immer dabei. Melden Sie sich an, damit Ihre Einstellungen gespeichert werden.

Jetzt anmelden

{"main_chart_height":350,"indicator_chart_height":80,"zoom":true,"show_dash":["chart-types","timespan","quicksearch","indicators","downloads"],"hover_tooltip":true,"i18n":{"de":{"Intraday":"1T","7d":"1W","1m":"1 Monat","3m":"3 Monate","6m":"6 Monate","1Y":"1 Jahr","3Y":"3 Jahre","5Y":"5 Jahre","10Y":"10 Jahre"}},"hover_labels":["open","high","low","close","performance"],"watermark":{"imgSrc":"https:\/\/www.goyax.de\/wp-content\/themes\/goyax\/assets\/images\/goyax-logo.svg","x":0.98,"y":0.98,"opacity":0.5,"height":31,"width":150},"xAxis":{"fontFamily":"Roboto","fontSize":14},"yAxis":{"fontFamily":"Roboto","fontSize":14,"showGrid":true},"technical_mode":true,"locked_features":{"features":["downloads-csv","timespan-10Y"],"redirect":"https:\/\/www.goyax.de\/anmelden\/?redirect=%2Faktien%2FUS02155H2004%2Faltimmune-inc%2F%3Fboerse%3Dham"},"show_volume":true,"indicators":[],"view_span":"5y","chart_type":"line","main_instrument":{"label":"Altimmune Inc.","params":{"isin":"US02155H2004","boerse":"ham","span":"5y"}},"chart_labels":["main"],"preset_indicators":[{"key":"ema","option":{"days":50,"color":"#1f77b4"}},{"key":"ema","option":{"days":200,"color":"#ff7f0e"}},{"key":"rsi"}],"quicksearch":{"url":"https:\/\/www.goyax.de\/wp-json\/goyax\/v1\/search","search_field":"s","params":{"charting":1}}}